Learn Deviation and Incident in Pharmaceuticals covering definitions, key differences, examples, GMP, and FAQs.
Deviation and Incident in Pharmaceuticals are critical quality events in the tightly regulated pharmaceutical industry, where strict compliance with Good Manufacturing Practices (GMP) is mandatory. Any departure from approved procedures or any unexpected event must be promptly identified, properly documented, and thoroughly investigated to ensure product quality, patient safety, and regulatory compliance.
Two commonly misunderstood terms in pharma quality systems are Deviation and Incident. Although they are related, they are not the same.
This article explains:
A Deviation is any departure from an approved process, procedure, specification, SOP, or expected outcome during GMP activities such as manufacturing, testing, packaging, or storage.
A tablet batch is required to blend for 20 minutes as per SOP, but blending is stopped after 15 minutes due to operator error.
This is an unplanned deviation and must be investigated.
Related: Regulatory Affairs
An Incident is an unplanned event that may impact operations, product quality, safety, or data integrity without necessarily involving a direct SOP violation.
Incidents often arise due to:
An HVAC failure overnight causes the cleanroom temperature to exceed limits. No manufacturing was in progress, but the event must still be assessed for potential impact.
| Feature | Deviation | Incident |
|---|---|---|
| Definition | Departure from approved SOP/process | Unplanned event affecting operations or quality |
| SOP Involvement | Always involves SOP or process | May or may not involve SOP |
| Examples | Skipped step, wrong parameter | Power failure, HVAC breakdown |
| Product Impact | May or may not impact the product | May or may not impact product |
| Documentation | Mandatory with RCA & CAPA | Mandatory impact assessment, CAPA if required |
Incorrect classification can lead to:
A strong Quality Management System (QMS) ensures that deviations and incidents are:
Deviation and incident management is not just about regulatory compliance—it is about protecting patients and maintaining product integrity. Clear understanding, proper documentation, and effective CAPA are essential elements of a robust pharmaceutical quality system.
By correctly identifying and managing deviations and incidents, pharma professionals strengthen GMP compliance, audit readiness, and operational excellence.
A deviation is a departure from an approved SOP or process, while an incident is an unplanned event that may impact quality or operations.
A deviation is any departure from an approved procedure, specification, or expected result.
An incident is an unplanned event that may or may not lead to a deviation.
A deviation that is pre-approved before execution under controlled conditions.
A deviation that occurs unexpectedly due to error, equipment failure, or process breakdown.
Using a raw material after its retest date without QA approval.
Power failure during batch processing, leading to equipment shutdown.
Yes. If an incident results in SOP non-compliance, it becomes a deviation.
CAPA is required if the incident has potential or actual impact.
Quality Assurance (QA) oversees deviation initiation, investigation, and closure.
Further reading:
Quick Links